Pages Menu
Categories Menu

Posted on Jan 8, 2008 in News

InnoMed Addresses Special Needs of Asians Suffering from Apnea with Customized Sleeping Aids

Business-Wire mini logo

COCONUT CREEK, Fla.–(BUSINESS WIRE)–The combination of a growing population of Asian-Americans and the effect of a Western diet on its eating habits has created a “sleeping giant,” or an increasing likelihood of the development of obstructive sleep apnea among this ethnic group.

In response, InnoMed Technologies Inc. of Coconut Creek, which competes with companies such as Resmed (NYSE:RMD) and Respironics (NASDAQ:RESP), is stepping to the forefront with medical innovations designed specifically to assist Asian sufferers of apnea. InnoMed’s Nasal-Aire® II Petite is a sleep interface that can accommodate the smaller nasal passages characteristic of traditional Asian features. Since no facial features are the same, the interface delivers air directly to the nose via a nasal cannula that comes in various sizes. The Nasal-Aire® Technology also comes with ergonomically designed Micro™ Headgear, featuring a patented elbow feature that reduces facial pressure points for added comfort.

Lightweight, soft, comfortable and quiet, the Nasal-Aire® II Petite is easy to fit, virtually leak-free, does not uncomfortably chill the nose and is easy to assemble and clean. The Nasal-Aire line of CPAP interface devices look and wear like an oxygen cannula. Experts predict this device to change the modality of CPAP delivery for treatment of sleep disorders and respiratory disorders and insufficiencies.

The research and marketing teams of InnoMed felt that Asian-Americans represented a significant segment of the U.S. population that could be served by their product line.

“We have found very few choices for fitting CPAP masks for the patient with especially smaller noses. The Innomed Nasal-Aire Petite provides us with a great option for the sometimes smaller facially featured patients,” Reggie Binns, CEO and Founder, New Millennium Sleep Diagnostics, Laguna Hills, CA.

According to the Archives of Pediatric and Adolescent Medicine, certain genetic and environmental risk factors have been identified in the development of sleep-disordered breathing (SDB); skull base length has been noted to be an ethnic risk factor in Far East Asians. The archives also noted that Far East Asian populations, along with African-Americans, have been shown to have significantly higher risk for SBD than Caucasians when age, sex and body mass index are considered.(1)

Further research on apnea and how it differs among other ethnic groups is scarce. Most studies have targeted obese, white males; however, several preliminary studies suggest that people of Asian descent suffer from apnea in similar ratios to Westerners without being obese or overweight.

The more common form of apnea is obstructive sleep apnea, where the throat muscles relax and collapse during sleep causing blockage in the airways. This may occur in both adults and children. People who experience this are roused from sleep to reopen their airway, often making a snorting, choking or gasping sound. Because this pattern occurs repeatedly, up to hundreds of times each hour all night long, it causes disruptions that impair a person’s ability to reach deep, restful phases of sleep, thus making him or her sleepy and tired during waking hours. For children, sleep apnea may impair learning, concentration and memory, not to mention physical growth.

For snoring, an initial symptom of apnea or SDB, simpler procedures, such as clearing the nasal passage by straightening the septum (septoplasty), reducing the size of the turbinates (radiofrequency turbinoplasty) or removing obstructions (endoscopic surgery for nasal polyps), are available. If the palate is the main source of snoring, then the latest wave in minimally invasive management is also offered.

For frank sleep apnea, positive airway pressure treatment is advised. This treatment involves a device that blows air into the patient’s airway through a mask to eliminate episodes of shallow breathing and obstruction. InnoMed’s Nasal-Aire® II Petite and the other InnoMed air interfaces can assist with the treatment and alleviation of apnea problems.

To learn more, visit InnoMed Technologies, Inc. is a forward-thinking medical technologies company poised to bring new and more effective medical products and devices to the public through its medical development and engineering team, as well as through acquisitions of other medical related companies. The company owns full utility patents and has patents pending.

InnoMed Technologies is a wholly owned subsidiary of Mergenet Solutions, Inc. To learn more about Mergenet Solutions and other companies in the Mergenet family, please

(1) Archives of Pediatric and Adolescent Medicine, Vol. 159, No. 8, August 2005

For InnoMed Technologies Inc., Coconut Creek
EMI Group Inc.
Elena Sher, 561-756-5551


Click here for our News Gallery.